angina market analysis, angina market research, angina market statistics, angina market industry trends, angina market share, angina market forecast
What are the recent trends in market size and growth for the angina market?
The angina market size has grown strongly in recent years. It will grow from $10.71 billion in 2024 to $11.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased prevalence of coronary heart disease, increased use of vasodilators, increased prevalence of myocardial ischemia, improved diagnostic capabilities, increased use of imaging techniques.
The angina market size is expected to see strong growth in the next few years. It will grow to $14.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing prevalence of chronic angina pectoris, rising drug approvals and clinical research, increasing demand for retail pharmacies, growing awareness of cardiovascular health, growing demand for medications. Major trends in the forecast period include technological advancements in early diagnosis, advancements in angioplasty and stenting, new gene therapy approaches, demand for coronary stents, advancements in coronary artery disease treatment.
Get Your Free Sample of The Global Angina Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp
How have varous drivers impacted the growth of the angina market?
The rising cases of coronary artery diseases are expected to propel the growth of the angina market going forward. Coronary artery disease (CAD), also known as coronary heart disease (CHD) or ischemic heart disease (IHD), is a condition characterized by the narrowing or blockage of the coronary arteries, which supply blood, oxygen, and nutrients to the heart muscle. The rising cases of coronary artery disease (CAD) are due to lifestyle changes and environmental and genetic factors. Angina plays a critical role in identifying and understanding the prevalence of coronary artery disease. Its presence prompts medical evaluation and diagnosis, helps stratify risk, guides treatment decisions, and informs public health strategies. For instance, in January 2023, according to the American Heart Association, from 2021 to 2022, the number of adults living with Coronary artery disease (CAD) in the U.S. rose from 18.2 million to approximately 19.3 million. Therefore, rising cases of coronary artery diseases drive the angina market.
What are the primary segments of the angina market?
The angina market covered in this report is segmented –
1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types
2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments
3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes
4) By Application: Clinics, Hospitals, Other Applications
Subsegments:
1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina
2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina
3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina
4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/angina-global-market-report
Which firms are leading the angina market?
Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals
How will industry trends affect the trajectory of the angina market?
Major companies operating in the angina market are developing innovative drugs such as metoprolol tartrate tablets to provide more effective and targeted treatments for patients who have coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are a form of medication commonly used to treat various cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, received final approval from the United States Food and Drug Administration (US-FDA) to manufacture and market its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta blocker used to treat various cardiovascular conditions, including high blood pressure (hypertension) and chest pain (angina), and to improve survival after a heart attack.
Which geographic trends are shaping the angina market, and which region has the highest market share?
North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Angina Market Report 2025 Offer?
The angina market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
